Robert T. Bailer
Impact in
- Virology top 0.1%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
Papers in
- Virology 36
- HIV Research and Treatment 34
- Immunology 28
- Immune Cell Function and Interaction 12
- Immunotherapy and Immune Responses 10
- Co-authors
- John R. Mascola (39 shared papers)Richard A. Koup (43 shared papers)Barney S. Graham (30 shared papers)Mary E. Enama (26 shared papers)Gary J. Nabel (22 shared papers)Mario Roederer (16 shared papers)Michael S. Seaman (6 shared papers)David C. Montefiori (6 shared papers)
- Journals
- Journal of Virology (10 papers)PLoS ONE (9 papers)The Journal of Infectious Diseases (5 papers)Vaccine (5 papers)Clinical and Vaccine Immunology (3 papers)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Robert T. Bailer
79 papers receiving 5.8k citations
Robert T. Bailer's Hit Papers
Peers
Comparison fields: 5 of 107
- Virology 2.5k
- Infectious Diseases 2.3k
- Immunology 2.2k
- Epidemiology 1.4k
- Radiology, Nuclear Medicine and Imaging 711
Countries citing papers authored by Robert T. Bailer
This map shows the geographic impact of Robert T. Bailer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Bailer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Bailer more than expected).
Fields of papers citing papers by Robert T. Bailer
This network shows the impact of papers produced by Robert T. Bailer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Bailer. The network helps show where Robert T. Bailer may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert T. Bailer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Broad and potent neutralization of HIV-1 by a gp41-specific human antibody Hit paper breakdown → | 2012 | 623 |
| 2 | 2007 | 379 | |
| 3 | 2013 | 297 | |
| 4 | 2013 | 231 | |
| 5 | 2006 | 228 | |
| 6 | 2008 | 199 | |
| 7 | 2013 | 194 | |
| 8 | 2014 | 183 | |
| 9 | 2006 | 170 | |
| 10 | 2015 | 151 | |
| 11 | 2011 | 150 | |
| 12 | 2006 | 150 | |
| 13 | 2010 | 145 | |
| 14 | 2007 | 133 | |
| 15 | 1986 | 126 | |
| 16 | 2011 | 116 | |
| 17 | 2006 | 114 | |
| 18 | 2009 | 111 | |
| 19 | 2005 | 107 | |
| 20 | 2010 | 101 |
About Robert T. Bailer
Robert T. Bailer is a scholar working on Virology, Immunology, Epidemiology, Infectious Diseases and Molecular Biology, having authored 79 papers that have together received 6.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (34 papers), Immune Cell Function and Interaction (12 papers), Influenza Virus Research Studies (10 papers), Immunotherapy and Immune Responses (10 papers), Hepatitis B Virus Studies (8 papers), HIV/AIDS drug development and treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and vaccines and immunoinformatics approaches (8 papers). The work is most often cited by research in Virology (2.5k citations), Infectious Diseases (2.3k citations), Immunology (2.2k citations), Epidemiology (1.4k citations) and Radiology, Nuclear Medicine and Imaging (711 citations). Robert T. Bailer has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include John R. Mascola, Richard A. Koup, Barney S. Graham, Mary E. Enama, Gary J. Nabel, Mario Roederer, Michael S. Seaman, David C. Montefiori, Charla Andrews and Mark K. Louder. Their work appears in journals such as Journal of Virology, PLoS ONE, The Journal of Infectious Diseases, Vaccine and Clinical and Vaccine Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.